Back to Search
ELISSA OSTRANDER, PHARMD
PHARMD
Pharmacist
NPI: 1386921492Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
50315(TX)
Research & Publications (20)
Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage.
PMID 19251732·Hum Mol Genet·2009
8-other
An expressed fgf4 retrogene is associated with breed-defining chondrodysplasia in domestic dogs.
PMID 19608863·Science·2009
7-preclinical
Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.
PMID 19346959·Genet Med·2009
8-other
Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.
PMID 19551860·Int J Cancer·2009
4-observational
Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.
PMID 19366828·Clin Cancer Res·2009
4-observational
Complex population structure in African village dogs and its implications for inferring dog domestication history.
PMID 19666600·Proc Natl Acad Sci U S A·2009
7-preclinical
Vitamin D pathway gene variants and prostate cancer risk.
PMID 19454612·Cancer Epidemiol Biomarkers Prev·2009
8-other
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
PMID 19223389·Hum Mol Genet·2009
8-other
Molecular and evolutionary history of melanism in North American gray wolves.
PMID 19197024·Science·2009
7-preclinical
Revisiting the missing protein-coding gene catalog of the domestic dog.
PMID 19193219·BMC Genomics·2009
7-preclinical
Linkage disequilibrium and demographic history of wild and domestic canids.
PMID 19189949·Genetics·2009
7-preclinical
A conserved active site tyrosine residue of proline dehydrogenase helps enforce the preference for proline over hydroxyproline as the substrate.
PMID 19140736·Biochemistry·2009
4-observational
Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
PMID 19366831·Clin Cancer Res·2009
4-observational
Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
PMID 19058137·Prostate·2009
8-other
Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.
PMID 18762813·Prostate Cancer Prostatic Dis·2009
8-other
No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees.
PMID 19476645·BMC Res Notes·2009
8-other
The role of the BRCA2 gene in susceptibility to prostate cancer revisited.
PMID 18708369·Cancer Epidemiol Biomarkers Prev·2008
6-review
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.
PMID 18708398·Cancer Epidemiol Biomarkers Prev·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 602 AVENUE Q
LUBBOCK, TX 79401 - Phone
- (806) 747-3834
Quick Facts
- NPI
- 1386921492
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile